Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Gynaecol Obstet ; 166(1): 305-311, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38328989

RESUMO

OBJECTIVES: To compare the efficacy, reasons for discontinuation and continuation rates of the etonogestrel (ENG)-subdermal contraceptive implant when offered at no cost, and the basis of free choice versus short-acting reversible contraceptive (SARC) methods including combined oral contraceptives (COCs), once-a-month injectables, vaginal ring, and patch. METHODS: We conducted a prospective study at the University of Campinas, Brazil, involving women aged 18 to 40 years. They were counseled on various contraceptive methods before entering the study and followed up every 3 months for up to 24 months. Satisfaction was assessed using a Likert scale. Survival rates were estimated using the Kaplan-Meier test, and curve comparisons were performed using the log-rank test. RESULTS: We enrolled 609 women including 358/609 women (58.8%) who chose the ENG-implant and 251/609 (41.2%) who chose SARC methods. Contraceptive failure and all other reasons for discontinuation were significantly higher in SARC users compared to the ENG-implant users (P < 0.001 and P = 0.002, respectively). The continuation rate was higher among ENG-implant users (89.9% and 75.4%) compared to SARC methods users (27.2% and 15.9%) up to 1 and 2 years after study initiation, respectively. Satisfaction was high in both groups (>82%). CONCLUSIONS: The ENG-implant showed higher contraceptive effectiveness and higher continuation rates than SARC methods up to 2 years after study initiation. Furthermore, users from both groups were highly satisfied with their contraceptive. The main reason for discontinuing use of the ENG-implant was bothersome uterine bleeding, while for SARC methods it was for personal reasons.


Assuntos
Anticoncepcionais Femininos , Desogestrel , Implantes de Medicamento , Humanos , Feminino , Desogestrel/administração & dosagem , Brasil , Adulto , Estudos Prospectivos , Adulto Jovem , Anticoncepcionais Femininos/administração & dosagem , Anticoncepcionais Femininos/economia , Adolescente , Satisfação do Paciente , Dispositivos Anticoncepcionais Femininos , Eficácia de Contraceptivos
3.
Eur J Contracept Reprod Health Care ; 22(5): 381-383, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29166843

RESUMO

OBJECTIVES: Our aim was to assess national hormonal and non-hormonal contraceptive sales in Brazil after the Zika virus outbreak. METHODS: Pharmaceutical companies based in Brazil provided data on monthly sales from September 2016 to June 2017. Data from both the public and private sectors were obtained about sales of registered, available modern contraceptive methods: combined oral contraceptive pill; progestin-only pill; vaginal and transdermal contraceptives; injectable contraceptives; long-acting reversible contraceptive (LARC) methods, including the copper-releasing intrauterine device, the levonorgestrel-releasing intrauterine system and the etonogestrel-releasing subdermal implant; and emergency contraceptive pills. RESULTS: Seventy-eight percent of sales comprised pills, patches and vaginal rings (11.1-13.8 million cycles/units per month), followed by emergency contraceptive pills (1.8-2.6 million pills), injectables (1.2-1.4 million ampoules) and LARC methods (6500-17,000 devices). CONCLUSIONS: The data showed much higher sales of short-acting methods compared with more effective LARC methods. The public sector needs to strengthen its focus on ensuring better access to LARC methods through a systematic approach ensuring regular supply, improved professional skills and better demand generation to couples wishing to avoid or delay pregnancy. In Zika virus-affected areas, many women of reproductive age may want to delay or postpone pregnancy by using an effective LARC method. The public sector should review its policies on LARC, as the need for these methods especially in Zika virus endemic areas may increase. A clear emphasis on quality in services, access and use is warranted.


Assuntos
Comércio/estatística & dados numéricos , Anticoncepção/economia , Epidemias/economia , Preparações Farmacêuticas/economia , Infecção por Zika virus/economia , Brasil/epidemiologia , Comércio/tendências , Anticoncepção/métodos , Anticoncepção/tendências , Anticoncepcionais Femininos/economia , Dispositivos Anticoncepcionais Femininos/economia , Humanos , Dispositivos Intrauterinos/economia , Infecção por Zika virus/epidemiologia
4.
Ginecol Obstet Mex ; 84(9): 551-6, 2016 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-29424969

RESUMO

Objetives: To identify the costs of family planning care in adolescents. Material and methods: Longitudinal study of the cost of care for family planning carried out in 2015 in a group of individuals with age limits of 10 and 19 years in a unit first level of health care in the state of Queretaro, Mexico. The profile of use of family planning (FP) was created for the teen was performed services through counseling, provision of contraception and review of intrauterine device (IUD) in a year; cost projections for the population of adolescents and different coverage scenarios between 5 and 100% were made. Results: The average annual cost was 228.84 Mexican pesos. Ideally the identified cost was 2,708.94 pesos. The projection with 20 % coverage was 207,251,330 pesos. The average annual family planning consultations was 0.9. The most commonly used method was with medroxyprogesterone-estradiol at doses of 25 and 5 mg. Conclusion: The cost of planning in adolescents is low, taking into account the costs that the care of high-risk pregnancies and associated comorbidities.


Assuntos
Anticoncepção/economia , Anticoncepcionais Femininos/economia , Serviços de Planejamento Familiar/economia , Dispositivos Intrauterinos/economia , Adolescente , Criança , Anticoncepção/métodos , Anticoncepcionais Femininos/administração & dosagem , Combinação de Medicamentos , Estradiol/administração & dosagem , Estradiol/economia , Feminino , Humanos , Estudos Longitudinais , Masculino , Acetato de Medroxiprogesterona/administração & dosagem , Acetato de Medroxiprogesterona/economia , México , Adulto Jovem
5.
Int Perspect Sex Reprod Health ; 39(4): 205-14, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24393726

RESUMO

CONTEXT: Oportunidades is a large conditional cash transfer program in Mexico. It is important to examine whether the program has any direct effect on pregnancy experience and contraceptive use among young rural women, apart from those through education. METHODS: Data from the 1992, 2006 and 2009 waves of a nationally representative, population-based survey were used to describe trends in pregnancy experience, contraceptive use and education among rural adolescent (15-19) and young adult (20-24) women in Mexico. To examine differences in pregnancy experience and current modern contraceptive use among young women, multivariable logistic regression analyses were conducted between matched 2006 samples of women with and without exposure to Oportunidades, predicted probabilities were calculated and indirect effects were estimated. RESULTS: Over the three survey waves, the proportion of adolescent and young adult women reporting ever being pregnant stayed flat (33-36%) and contraceptive use increased steadily (from 13% in 1992 to 19% in 2009). Educational attainment rose dramatically: The proportion of women with a secondary education increased from 28% in 1992 to 46% in 2009. In multivariable analyses, exposure to Oportunidades was not associated with pregnancy experience among adolescents. Educational attainment, marital status, pregnancy experience and access to health insurance--but not exposure to Oportunidades--were positively associated with current modern contraceptive use among adolescent and young adult women. CONCLUSION: Through its effect on education, Oportunidades indirectly influences fertility among adolescents. It is important for Mexico to focus on strategies to increase contraceptive use among young rural nulliparous women, regardless of whether they are enrolled in Oportunidades.


Assuntos
Anticoncepção/economia , Anticoncepção/estatística & dados numéricos , Anticoncepcionais Femininos/economia , Serviços de Planejamento Familiar/economia , Financiamento Governamental/economia , Acessibilidade aos Serviços de Saúde/economia , População Rural/estatística & dados numéricos , Adolescente , Anticoncepcionais Femininos/uso terapêutico , Feminino , Financiamento Governamental/estatística & dados numéricos , Educação em Saúde/economia , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Humanos , Bem-Estar Materno/economia , México/epidemiologia , Educação de Pacientes como Assunto/economia , Pobreza/estatística & dados numéricos , Gravidez , Serviços de Saúde Rural/economia , Saúde da Mulher/economia , Adulto Jovem
6.
Contraception ; 86(3): 244-50, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22459236

RESUMO

BACKGROUND: Heavy menstrual bleeding (HMB) is the most common complaint of women seeking gynecological care. Treatments included surgical or medical options including hysterectomy and the levonorgestrel-releasing intrauterine system (LNG-IUS) due to the profound suppression of endometrial growth that intrauterine LNG exerts which results in amenorrhea or in a reduction of blood loss. OBJECTIVE: The study was conducted to evaluate the resources and procedures involved in inserting an LNG-IUS compared to performing hysterectomy in women with HMB in a public sector hospital in Brazil. STUDY DESIGN: Two cohorts of women were studied: women who accepted an LNG-IUS (n=124) and matched women who underwent hysterectomy on the same day (n=122). We evaluate the number of procedures carried out in each group of women, including those performed before the decision was made to insert an LNG-IUS or to perform hysterectomy, the insertion of the device itself and the surgical procedure, in addition to the procedures and complications registered up to 1 year after LNG-IUS insertion or hysterectomy. RESULTS: Age and the duration of HMB were significantly lower in the LNG-IUS acceptors than women at the hysterectomy group. The numbers of gynecological consultations and Pap smears were similar in both groups; however, women in the hysterectomy group also underwent laboratory tests, ultrasonography, chest X-ray and electrocardiogram. In the hysterectomy group, the main complications were hemorrhage (six), bladder/bowel perforation (four), complications with anesthesia (one), ureteral reimplantation required (one) and abdominal pain (two). At 1 year, HMB was controlled in 83.1% of women in the LNG-IUS group, and 106 women continued with the device. CONCLUSIONS: Both treatments were effective in HMB control. Fewer resources and complications were observed in LNG-IUS acceptors when compared to hysterectomy. The LNG-IUS represents a good strategy for reducing the number of hysterectomies and the resources required for women with HMB.


Assuntos
Anticoncepcionais Femininos/uso terapêutico , Histerectomia/estatística & dados numéricos , Levanogestrel/uso terapêutico , Menorragia/terapia , Adulto , Brasil , Estudos de Coortes , Anticoncepcionais Femininos/economia , Feminino , Recursos em Saúde/estatística & dados numéricos , Humanos , Histerectomia/economia , Expulsão de Dispositivo Intrauterino , Dispositivos Intrauterinos Medicados , Levanogestrel/economia , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia
7.
Expert Opin Emerg Drugs ; 16(2): 373-87, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21235423

RESUMO

INTRODUCTION: Fifty years after the first contraceptive, the market remains restricted regarding composition, cost and routes of administration, and satisfying the needs of millions of women with different requirements according to their stage in life. AREAS COVERED: Women need contraception for almost 30 years of their life. Currently available contraceptives are highly effective with few side effects. This review provides information on emerging female contraceptives including some registered and others at different stages of development. Research efforts aim to reduce costs, improve acceptability and refine 'forgettable' reversible methods. Although developing and testing a new method is laborious and expensive, many new contraceptives are currently under development including different routes of administration. EXPERT OPINION: New methods should be affordable, simple to use and suitable for many women. Much work remains to be done and new methods that act on the fusion process between both gametes are desirable without affecting the hormonal milieu.


Assuntos
Anticoncepcionais Femininos/administração & dosagem , Animais , Anticoncepcionais Femininos/efeitos adversos , Anticoncepcionais Femininos/economia , Descoberta de Drogas/métodos , Feminino , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA